PDK1 and neoplasm: Dichloroacetate (DCA), a PDK1 inhibitor, reverses the metabolic phenotype of tumor cells, shifting the metabolic flux to mitochondrial oxidative phosphorylation, which induces selective cytotoxicity 24-26.